Health News Archive - February 19, 2010
EAST HANOVER, N.J., Feb.
LONDON, Feb. 19 /PRNewswire/ -- Freedom Healthnet (http://www.freedomhealthnet.com/http://www.freedomhealthnet.com/) today affirmed the benefits of private health insurance as the company prepares to launch a range of new products.
SILVER SPRING, Md., Feb.
VIRGINIA BEACH, Va., Feb. 19, 2010 /PRNewswire-FirstCall/ -- Amerigroup Corporation (NYSE: AGP) today announced that net income for the fourth quarter of 2009 was $40.2 million, or $0.79 per diluted share, versus $35.9 million, or $0.67 per diluted share, for the fourth quarter of 2008.
ROCKVILLE, Md., Feb. 19 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) today presented to the world's leading pandemic influenza vaccine experts a summary of the recent preliminary safety and immunogenicity data from its Pivotal 2009 A/H1N1 VLP pandemic influenza vaccine study in Mexico.
SAN CLEMENTE, Calif., Feb. 19 /PRNewswire-FirstCall/ -- Micro Imaging Technology, Inc. (OTC: Bulletin Board: MMTC) today announced that it has changed is company name to Micro Identification Technologies to better reflect the extensive capabilities of its ID technology software.
TORONTO, Feb. 19 /PRNewswire-FirstCall/ - MDS Inc.
MISSISSAUGA, ON, Feb. 19 /PRNewswire-FirstCall/ - Nuvo Research Inc.
DUBLIN, February 19, 2010 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY) the global specialty biopharmaceutical company, announces results for the year to December 31, 2009. Financial Highlights Full Year 2009(1) Q4 2009(1) Product sales $2,694 million -2% $777 million +10% Product sales from core products(2) $2,067 million +25% $585 million +36% Total revenues $3,008 million 0% $893 million +17% Non GAAP operating income $889 million -7% $313 million +30% US GAAP operating income $620 million +51% $268 million +39% Non GAAP diluted earnings per ADS $3.49 -10% $1.11 +9% US GAAP diluted earnings per ADS $2.69 +214% $0.94 +20% These results include the effect of a change in best estimate o
GAITHERSBURG, Md., Feb. 19 /PRNewswire-FirstCall/ -- Today GenVec, Inc.
- A person or thing gazed at with wonder or curiosity, especially of a scornful kind.